Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Berlin - Delayed Quote EUR

Syros Pharmaceuticals Inc (0S90.BE)

Compare
0.1380
-0.0050
(-3.50%)
At close: 9:40:04 PM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
386
9,936
14,880
23,488
15,093
Operating Expense
111,908
136,435
141,243
122,908
97,390
Operating Income
-111,522
-126,499
-126,363
-99,420
-82,297
Net Non Operating Interest Income Expense
-623
1,689
-2,002
-3,820
-1,366
Other Income Expense
14,330
-39,764
33,711
16,682
-375
Pretax Income
-97,815
-164,574
-94,654
-86,558
-84,038
Net Income Common Stockholders
-97,815
-164,574
-94,654
-86,558
-84,038
Diluted NI Available to Com Stockholders
-97,815
-164,574
-94,654
-86,558
-84,038
Basic EPS
-4.35
-5.81
-7.49
-13.84
-18.20
Diluted EPS
-4.35
-5.81
-7.49
-13.84
-18.20
Basic Average Shares
33,948.6340
28,325.7790
12,631.9680
6,253.4980
4,605.1620
Diluted Average Shares
33,948.6340
28,325.7790
12,631.9680
6,253.4980
4,605.1620
Total Operating Income as Reported
-111,657
-128,988
-135,873
-99,420
-82,297
Total Expenses
111,908
136,435
141,243
122,908
97,390
Net Income from Continuing & Discontinued Operation
-97,815
-164,574
-94,654
-86,558
-84,038
Normalized Income
-112,145
-124,810
-128,365
-103,240
-83,663
Interest Income
4,707
6,816
2,132
87
426
Interest Expense
5,330
5,127
4,134
3,907
1,792
Net Interest Income
-623
1,689
-2,002
-3,820
-1,366
EBIT
-92,485
-159,447
-90,520
-82,651
-82,246
EBITDA
-91,143
-157,195
-87,814
-79,633
-79,211
Reconciled Depreciation
1,342
2,252
2,706
3,018
3,035
Net Income from Continuing Operation Net Minority Interest
-97,815
-164,574
-94,654
-86,558
-84,038
Total Unusual Items Excluding Goodwill
14,330
-39,764
33,711
16,682
-375
Total Unusual Items
14,330
-39,764
33,711
16,682
-375
Normalized EBITDA
-105,473
-117,431
-121,525
-96,315
-78,836
12/31/2020 - 9/21/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0M4.DU Mersana Therapeutics Inc
0.4706
-5.35%
 
0M4.SG Mersana Therapeutics Inc
0.4769
-1.22%
 
AT20.F Atara Biotherapeutics, Inc.
6.55
-5.76%
 
8AW0.SG Ocean Biomedical Inc
0.0915
+0.55%
 
RYI.BE Viracta Therapeutics Inc
0.0000
0.00%
 
8AW0.MU Ocean Biomedical Inc
0.0965
-3.50%
 
8AW0.F Ocean Biomedical, Inc.
0.0860
-3.37%
 
8AW0.BE Ocean Biomedical Inc
0.0945
-2.07%
 
0M4.F Mersana Therapeutics, Inc.
0.4243
-1.94%
 
NV4.F Cellectar Biosciences, Inc.
0.2800
+6.87%